FDA OKs Genentech drug for early breast cancer
17th Nov 2006, 00:01 GMT
LOS ANGELES (Reuters) - The U.S. Food and Drug Administration has agreed to expand the use of Genentech Inc.'s breast cancer drug Herceptin to include women with early-stage cancer who have undergone surgery, the company said on Thursday.
Latest news from Reuters: Health:
- Roche flu drug to carry new caution in U.S.
- Gene chip test identifies bird flu strains
- Bristol arthritis drug effective in children: study
- World's poor still deprived of drugs: activists
- Study questions radiation after prostate removal
- Chocolate addiction leads to sweet discovery
- Researchers spur growth of adult brain stem cells
- Angioplasty no help for heart attack victims who wait
- Diabetics fare better with drug-eluting stents
- Very obese fare worse after colon cancer diagnosis